Bioequivalence Study of SB797620 in Healthy Japanese Volunteers
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will test whether the Drug levels in plasma after combination formulation tablet
dosing (SB797620) and separate formulation tablets dosing (rosiglitazone and glimepiride) to
Japanese Healthy volunteer would be the same or not.